[Lani]

Items 1 - 10 of 10
One page.
1:
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.
Colozza M, Minenza E, Gori S, Fenocchio D, Paolucci C, Aristei C, Floridi P.
Cancer Chemother Pharmacol. 2008 Nov 6. [Epub ahead of print] No abstract available.
PMID: 18987856 [PubMed - as supplied by publisher]



2:
High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.
Mir O, Ropert S, Alexandre J, Lemare F, Goldwasser F.
Ann Oncol. 2008 Nov;19(11):1978-80. Epub 2008 Oct 9. No abstract available.
PMID: 18845838 [PubMed - indexed for MEDLINE]



3:
Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ, Mengele K, Schmitt M, Harbeck N, Laessig D, Herrmann KA, Schaffer P, Heinemann V.
Anticancer Drugs. 2008 Sep;19(8):832-6.
PMID: 18690096 [PubMed - indexed for MEDLINE]


4:
[Two cases treated with trastuzumab as primary chemotherapy]
Murakami K, Sakata H, Miyazawa Y, Matsushita K, Akutsu Y, Nishimori T, Yoneyama Y, Usui A, Kano M, Matsubara H, Ochiai T.
Gan To Kagaku Ryoho. 2007 Oct;34(10):1683-7. Japanese.
PMID: 17940391 [PubMed - indexed for MEDLINE]



5:
CNS complications of breast cancer: current and emerging treatment options.
Kaal EC, Vecht CJ.
CNS Drugs. 2007;21(7):559-79. Review.
PMID: 17579499 [PubMed - indexed for MEDLINE]



6:
Care with intrathecal trastuzumab.
Siderov J.
Lancet Oncol. 2006 Nov;7(11):888. No abstract available.
PMID: 17081914 [PubMed - indexed for MEDLINE]



7:
Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab.
Platini C, Long J, Walter S.
Lancet Oncol. 2006 Sep;7(9):778-80. No abstract available.
PMID: 16945774 [PubMed - indexed for MEDLINE]



8:
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.
Stemmler HJ, Schmitt M, Harbeck N, Willems A, Bernhard H, Lässig D, Schoenberg S, Heinemann V.
Oncol Rep. 2006 May;15(5):1373-7.
PMID: 16596213 [PubMed - indexed for MEDLINE]



9:
Intrathecal therapy with trastuzumab may be beneficial in cases of refractory schizophrenia.
Sastry PS, Sita Ratna W.
Med Hypotheses. 2004;62(4):542-5.
PMID: 15050103 [PubMed - indexed for MEDLINE]


10:
Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
Laufman LR, Forsthoefel KF.
Clin Breast Cancer. 2001 Oct;2(3):235. No abstract available.
PMID: 11899418 [PubMed - indexed for MEDLINE]